Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Benson AB 3rd, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Gurski L, Freedman-Cass DA.

J Natl Compr Canc Netw. 2018 Jul;16(7):874-901. doi: 10.6004/jnccn.2018.0061.

PMID:
30006429
2.

Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Benson AB 3rd, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Freedman-Cass DA.

J Natl Compr Canc Netw. 2018 Jul;16(7):852-871. doi: 10.6004/jnccn.2018.0060.

PMID:
30006428
3.

NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018.

Shah MH, Goldner WS, Halfdanarson TR, Bergsland E, Berlin JD, Halperin D, Chan J, Kulke MH, Benson AB, Blaszkowsky LS, Eads J, Engstrom PF, Fanta P, Giordano T, He J, Heslin MJ, Kalemkerian GP, Kandeel F, Khan SA, Kidwai WZ, Kunz PL, Kuvshinoff BW, Lieu C, Pillarisetty VG, Saltz L, Sosa JA, Strosberg JR, Sussman CA, Trikalinos NA, Uboha NA, Whisenant J, Wong T, Yao JC, Burns JL, Ogba N, Zuccarino-Catania G.

J Natl Compr Canc Netw. 2018 Jun;16(6):693-702. doi: 10.6004/jnccn.2018.0056.

PMID:
29891520
4.

NCCN Guidelines Insights: Colon Cancer, Version 2.2018.

Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Garrido-Laguna I, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Freedman-Cass DA.

J Natl Compr Canc Netw. 2018 Apr;16(4):359-369. doi: 10.6004/jnccn.2018.0021.

PMID:
29632055
5.

Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.

Benson AB 3rd, Venook AP, Cederquist L, Chan E, Chen YJ, Cooper HS, Deming D, Engstrom PF, Enzinger PC, Fichera A, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wu CS, Gregory KM, Freedman-Cass D.

J Natl Compr Canc Netw. 2017 Mar;15(3):370-398.

PMID:
28275037
6.

Association Between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast Cancer.

Newman LA, Stark A, Chitale D, Pepe M, Longton G, Worsham MJ, Nathanson SD, Miller P, Bensenhaver JM, Proctor E, Swain M, Patriotis C, Engstrom PF.

JAMA Oncol. 2017 Aug 1;3(8):1102-1106. doi: 10.1001/jamaoncol.2016.5598.

7.

Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study.

Vijayvergia N, Boland PM, Handorf E, Gustafson KS, Gong Y, Cooper HS, Sheriff F, Astsaturov I, Cohen SJ, Engstrom PF.

Br J Cancer. 2016 Aug 23;115(5):564-70. doi: 10.1038/bjc.2016.229. Epub 2016 Aug 2.

8.

Rectal Cancer, Version 2.2015.

Benson AB 3rd, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS, Engstrom PF, Enzinger PC, Fenton MJ, Fuchs CS, Grem JL, Grothey A, Hochster HS, Hunt S, Kamel A, Kirilcuk N, Leong LA, Lin E, Messersmith WA, Mulcahy MF, Murphy JD, Nurkin S, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Gregory KM, Freedman-Cass D.

J Natl Compr Canc Netw. 2015 Jun;13(6):719-28; quiz 728.

PMID:
26085388
9.

Neuroendocrine tumors, version 1.2015.

Kulke MH, Shah MH, Benson AB 3rd, Bergsland E, Berlin JD, Blaszkowsky LS, Emerson L, Engstrom PF, Fanta P, Giordano T, Goldner WS, Halfdanarson TR, Heslin MJ, Kandeel F, Kunz PL, Kuvshinoff BW 2nd, Lieu C, Moley JF, Munene G, Pillarisetty VG, Saltz L, Sosa JA, Strosberg JR, Vauthey JN, Wolfgang C, Yao JC, Burns J, Freedman-Cass D; National comprehensive cancer network.

J Natl Compr Canc Netw. 2015 Jan;13(1):78-108.

PMID:
25583772
10.

Colon cancer, version 3.2014.

Benson AB 3rd, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS, Engstrom PF, Enzinger PC, Fenton MJ, Fuchs CS, Grem JL, Hunt S, Kamel A, Leong LA, Lin E, Messersmith W, Mulcahy MF, Murphy JD, Nurkin S, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Gregory KM, Freedman-Cass DA; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2014 Jul;12(7):1028-59.

PMID:
24994923
11.

A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers.

Denlinger CS, Meropol NJ, Li T, Lewis NL, Engstrom PF, Weiner LM, Cheng JD, Alpaugh RK, Cooper H, Wright JJ, Cohen SJ.

Clin Colorectal Cancer. 2014 Jun;13(2):81-6. doi: 10.1016/j.clcc.2013.12.005. Epub 2014 Jan 4.

12.

Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines.

Benson AB 3rd, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Engstrom PF, Enzinger PC, Fakih MG, Fenton MJ, Fuchs CS, Grem JL, Hunt S, Kamel A, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W Jr, Sofocleous CT, Venook AP, Willett CG, Gregory KM, Freedman-Cass DA; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2013 May 1;11(5):519-28.

PMID:
23667203
13.

Physician burnout.

Engstrom PF.

J Natl Compr Canc Netw. 2013 Apr 1;11(4):502-4. No abstract available.

PMID:
23584350
14.

Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines.

Benson AB 3rd, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Engstrom PF, Enzinger PC, Fakih MG, Fenton MJ, Fuchs CS, Grem JL, Hunt S, Kamel A, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W Jr, Sofocleous CT, Venook AP, Willett CG, Gregory KM, Freedman-Cass DA.

J Natl Compr Canc Netw. 2013 Feb 1;11(2):141-52; quiz 152.

PMID:
23411381
15.

Rectal cancer.

Benson AB 3rd, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Engstrom PF, Enzinger PC, Fakih MG, Fuchs CS, Grem JL, Hunt S, Leong LA, Lin E, Martin MG, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W Jr, Sofocleous CT, Venook AP, Willett CG, Freedman-Cass DA, Gregory KM.

J Natl Compr Canc Netw. 2012 Dec 1;10(12):1528-64.

PMID:
23221790
16.

Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis.

Khrizman P, Niland JC, ter Veer A, Milne D, Bullard Dunn K, Carson WE 3rd, Engstrom PF, Shibata S, Skibber JM, Weiser MR, Schrag D, Benson AB 3rd.

J Clin Oncol. 2013 Jan 1;31(1):30-8. doi: 10.1200/JCO.2011.40.3188. Epub 2012 Nov 19.

17.

Genetic analysis of polymorphisms in dopamine receptor and transporter genes for association with smoking among cancer patients.

Gordiev M, Engstrom PF, Khasanov R, Moroshek A, Sitdikov R, Dgavoronkov V, Schnoll RA.

Eur Addict Res. 2013;19(2):105-11. doi: 10.1159/000341711. Epub 2012 Nov 2.

18.

Neuroendocrine tumors.

Kulke MH, Benson AB 3rd, Bergsland E, Berlin JD, Blaszkowsky LS, Choti MA, Clark OH, Doherty GM, Eason J, Emerson L, Engstrom PF, Goldner WS, Heslin MJ, Kandeel F, Kunz PL, Kuvshinoff BW 2nd, Moley JF, Pillarisetty VG, Saltz L, Schteingart DE, Shah MH, Shibata S, Strosberg JR, Vauthey JN, White R, Yao JC, Freedman-Cass DA, Dwyer MA; National Comprehensive Cancer Networks.

J Natl Compr Canc Netw. 2012 Jun 1;10(6):724-64.

PMID:
22679117
19.

Ten years of progress in colon cancer therapy.

Engstrom PF.

J Natl Compr Canc Netw. 2012 May;10(5):574-6. No abstract available.

PMID:
22570287
20.

Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines.

Benson AB 3rd, Arnoletti JP, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Engstrom PF, Enzinger PC, Fakih MG, Fleshman JW Jr, Fuchs CS, Grem JL, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W Jr, Sofocleous CT, Venook AP, Willett C, Freedman-Cass DA; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2012 Apr;10(4):449-54.

PMID:
22491045
21.

NCCN molecular testing white paper: effectiveness, efficiency, and reimbursement.

Engstrom PF, Bloom MG, Demetri GD, Febbo PG, Goeckeler W, Ladanyi M, Loy B, Murphy K, Nerenberg M, Papagni P, Robson M, Sweetman RW, Tunis S, Demartino J, Larsen JK; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2011 Dec;9 Suppl 6:S1-16.

PMID:
22203777
22.

Colon cancer.

Benson AB 3rd, Arnoletti JP, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Engstrom PF, Enzinger PC, Fleshman JW Jr, Fuchs CS, Grem JL, Knol JA, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W Jr, Sofocleous CT, Venook AP, Willett C; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2011 Nov;9(11):1238-90. No abstract available.

PMID:
22056656
23.

Assessing compliance with national comprehensive cancer network guidelines for elderly patients with stage III colon cancer: the Fox Chase Cancer Center Partners' initiative.

O'Grady MA, Slater E, Sigurdson ER, Meropol NJ, Weinstein A, Lusch CJ, Sein E, Keeley P, Miller B, Engstrom PF, Cohen SJ.

Clin Colorectal Cancer. 2011 Jun;10(2):113-6. doi: 10.1016/j.clcc.2011.03.007. Epub 2011 Apr 22.

24.

Emerging therapies for advanced gastroenteropancreatic neuroendocrine tumors.

Gupta S, Engstrom PF, Cohen SJ.

Clin Colorectal Cancer. 2011 Dec;10(4):298-309. doi: 10.1016/j.clcc.2011.06.006. Epub 2011 Aug 2. Review.

PMID:
21813338
25.

Modification and implementation of NCCN guidelines on colon cancer in the Middle East and North Africa region.

IƧli F, Akbulut H, Bazarbashi S, Kuzu MA, Mallath MK, Rasul KI, Strong S, Syed AA, Zorlu F, Engstrom PF; MENA Colon Cancer Regional Guidelines Committee.

J Natl Compr Canc Netw. 2010 Jul;8 Suppl 3:S22-5.

PMID:
20697127
26.

Colorectal cancer survivorship: movement matters.

Denlinger CS, Engstrom PF.

Cancer Prev Res (Phila). 2011 Apr;4(4):502-11. doi: 10.1158/1940-6207.CAPR-11-0098. Review.

27.

Correlates of continued tobacco use and intention to quit smoking among Russian cancer patients.

Schnoll RA, Subramanian S, Martinez E, Engstrom PF.

Int J Behav Med. 2011 Dec;18(4):325-32. doi: 10.1007/s12529-010-9131-8.

28.

Defining venous involvement in borderline resectable pancreatic cancer.

Chun YS, Milestone BN, Watson JC, Cohen SJ, Burtness B, Engstrom PF, Haluszka O, Tokar JL, Hall MJ, Denlinger CS, Astsaturov I, Hoffman JP.

Ann Surg Oncol. 2010 Nov;17(11):2832-8. doi: 10.1245/s10434-010-1284-9. Epub 2010 Aug 20.

PMID:
20725860
29.

Cancer of unknown primary site.

Morris GJ, Greco FA, Hainsworth JD, Engstrom PF, Scialla S, Jordan WE 3rd, Thomas LC.

Semin Oncol. 2010 Apr;37(2):71-9. doi: 10.1053/j.seminoncol.2010.03.009. Review. No abstract available.

PMID:
20494696
30.

NCCN clinical practice guidelines in oncology. Anal carcinoma.

Engstrom PF, Arnoletti JP, Benson AB 3rd, Berlin JD, Berry JM, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J Jr, Fuchs C, Grem JL, Knol JA, Leong LA, Lin E, Mulcahy MF, Rohren E, Ryan DP, Saltz L, Shibata D, Skibber JM, Small W, Sofocleous C, Thomas J, Venook AP, Willett C; NCCN.

J Natl Compr Canc Netw. 2010 Jan;8(1):106-20. No abstract available.

PMID:
20064293
31.

NCCN Clinical Practice Guidelines in Oncology: rectal cancer.

Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J Jr, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2009 Sep;7(8):838-81. No abstract available.

PMID:
19755047
32.

NCCN Clinical Practice Guidelines in Oncology: colon cancer.

Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J Jr, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2009 Sep;7(8):778-831. No abstract available.

PMID:
19755046
33.

Discussing colorectal cancer.

Engstrom PF.

J Natl Compr Canc Netw. 2009 Sep;7(8):776. No abstract available.

PMID:
19755045
34.

NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors.

Clark OH, Benson AB 3rd, Berlin JD, Choti MA, Doherty GM, Engstrom PF, Gibbs JF, Heslin MJ, Kessinger A, Kulke MH, Kvols L, Salem R, Saltz L, Shah MH, Shibata S, Strosberg JR, Yao JC; NCCN Neuroendocrine Tumors Panel Members.

J Natl Compr Canc Netw. 2009 Jul;7(7):712-47. No abstract available.

PMID:
19635226
36.

Phase I study of capecitabine and oxaliplatin in combination with the proteasome inhibitor bortezomib in patients with advanced solid tumors.

Cohen SJ, Engstrom PF, Lewis NL, Langer CJ, McLaughlin S, Beard M, Weiner LM, Meropol NJ.

Am J Clin Oncol. 2008 Feb;31(1):1-5. doi: 10.1097/COC.0b013e31805c142f.

PMID:
18376220
37.

Rectal cancer.

Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Early DS, Fakih MG, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW Jr, Rao S, Saltz L, Shibata D, Skibber JM, Venook AP; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2007 Oct;5(9):940-81. No abstract available.

PMID:
17977503
38.

Colon cancer.

Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Early DS, Fakih MG, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW Jr, Rao S, Saltz L, Shibata D, Skibber JM, Venook AP; Fox Chase Cancer Center Partners.

J Natl Compr Canc Netw. 2007 Oct;5(9):884-925. No abstract available.

PMID:
17977501
39.

Successful application of microarray technology to microdissected formalin-fixed, paraffin-embedded tissue.

Coudry RA, Meireles SI, Stoyanova R, Cooper HS, Carpino A, Wang X, Engstrom PF, Clapper ML.

J Mol Diagn. 2007 Feb;9(1):70-9.

40.

Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.

Kelloff GJ, Lippman SM, Dannenberg AJ, Sigman CC, Pearce HL, Reid BJ, Szabo E, Jordan VC, Spitz MR, Mills GB, Papadimitrakopoulou VA, Lotan R, Aggarwal BB, Bresalier RS, Kim J, Arun B, Lu KH, Thomas ME, Rhodes HE, Brewer MA, Follen M, Shin DM, Parnes HL, Siegfried JM, Evans AA, Blot WJ, Chow WH, Blount PL, Maley CC, Wang KK, Lam S, Lee JJ, Dubinett SM, Engstrom PF, Meyskens FL Jr, O'Shaughnessy J, Hawk ET, Levin B, Nelson WG, Hong WK; AACR Task Force on Cancer Prevention.

Clin Cancer Res. 2006 Jun 15;12(12):3661-97. Review.

41.

Prevalence and correlates of tobacco use among Russian cancer patients: implications for the development of smoking cessation interventions at a cancer center in Russia.

Schnoll RA, Engstrom PF, Subramanian S, Demidov L, Wielt DB, Tighiouart M.

Int J Behav Med. 2006;13(1):16-25.

PMID:
16503837
42.

Smoking cessation counseling by Russian oncologists: opportunities for intervention in the Russian Federation.

Schnoll RA, Engstrom PF, Subramanian S, Demidov L, Wielt DB.

Int J Behav Med. 2006;13(1):8-15.

PMID:
16503836
43.

Neuroendocrine tumors.

Clark OH, Ajani J, Benson AB 3rd, Byrd D, Doherty GM, Engstrom PF, Ettinger DS, Gibbs JF, Heslin MJ, Kandeel F, Kessinger A, Kulke MH, Kvols L, Nemcek AA Jr, Olson JA Jr, Ratliff TW, Saltz L, Schteingart DE, Shah MH, Shibata S; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2006 Feb;4(2):102-38. Review. No abstract available.

PMID:
16451769
44.

Senior adult oncology clinical practice guidelines in oncology.

Balducci L, Cohen HJ, Engstrom PF, Ettinger DS, Halter J, Gordon LI, Kiel K, Kneier A, Lim D, Petersdorf SH, Rosenthal R, Silliman R, Vose JM, Walker MJ, Zachariah B; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2005 Jul;3(4):572-90. No abstract available.

PMID:
16038647
45.

Anal canal cancer clinical practice guidelines in oncology.

Engstrom PF, Benson AB 3rd, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW Jr, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2005 Jul;3(4):510-5. No abstract available.

PMID:
16038641
46.

Rectal cancer clinical practice guidelines in oncology.

Engstrom PF, Benson AB 3rd, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW Jr, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2005 Jul;3(4):492-508. No abstract available.

PMID:
16038640
47.

Colon cancer clinical practice guidelines in oncology.

Engstrom PF, Benson AB 3rd, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW Jr, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2005 Jul;3(4):468-91. No abstract available.

PMID:
16038639
48.

Change in worksite smoking behavior following cancer risk feedback: a pilot study.

Schnoll RA, Wang H, Miller SM, Babb JS, Cornfeld MJ, Tofani SH, Hennigan-Peel T, Balshem A, Slater E, Ross E, Boyd CS, Engstrom PF.

Am J Health Behav. 2005 May-Jun;29(3):215-27.

PMID:
15899685
49.

Update: NCCN colon and rectal cancer clinical practice guidelines.

Kiel K, Engstrom PF.

J Natl Compr Canc Netw. 2004 Sep;2 Suppl 3:S-14-8. No abstract available.

PMID:
23570093
50.

Tobacco control in the physician's office: a matter of adequate training and resources.

Schnoll RA, Engstrom PF.

J Natl Cancer Inst. 2004 Apr 21;96(8):573-5. No abstract available.

PMID:
15100328

Supplemental Content

Loading ...
Support Center